プレシジョン・メディシン・リサーチ

Single-cell sequencing is a rapidly evolving approach to delve into the genomic, transcriptomic, epigenomic, and proteomic landscapes of single cells.

Technological advancements have rapidly boosted the adoption of single-cell sequencing experiments – by increasing the number of cells analyzed and reducing the cost and complexity. 

When it comes to health and lives, improved accuracy and urgency are essential. And the best way to have that is through better profiling.

Join us for an insightful on-demand webinar which delves into the realm of cell-free biomarker discovery, presented by Bessie Meechoovet from the esteemed Dr. Kendall van Keuren-Jensen Lab at the Translational Genomics Research Institute (TGen). 

Researchers at the Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, are demonstrating how functional screening of 3D patient-derived cancer cells enables effective drug sensitivity testing and the ability to potentially tailor medicines to an individual patient.